Evidence map›Paper›PMID 26157176›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Sirtuin 1 Regulates Dendritic Cell Activation and Autophagy during Respiratory Syncytial Virus-Induced Immune Responses.

Anna B Owczarczyk, Matthew A Schaller, Michelle Reed, Andrew J Rasky, David B Lombard, Nicholas W Lukacs

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Immunosenescence: signaling pathways, diseases and therapeutic targets.Signal transduction and targeted therapy · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. A Balance Between Autophagy and Other Cell Death Modalities in Cancer.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anna B OwczarczykDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and.
Matthew A SchallerDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and.
Michelle ReedDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and.
Andrew J RaskyDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and.
David B LombardDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and Institute of Gerontology, University of Michigan Medical School, Ann Arbor, MI 48109.
Nicholas W LukacsDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and nlukacs@med.umich.edu.
University of Michigan–Ann Arbor · US

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
The Role of C-C Chemokines in Eosinophil Airway InflammationR01AI036302 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKACS, NICHOLAS W · 2001 to 2018
$5.6M
Autophagy regulation of RSV-induced pulmonary diseaseR01HL114858 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LOMBARD, DAVID BENNER, LUKACS, NICHOLAS W · 2012 to 2019
$3.2M
Regulation of one carbon metabolism and epigenetics by SIRT5R01GM101171 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LOMBARD, DAVID BENNER · 2012 to 2021
$2.6M
Mechanisms of tumor suppression by the chromatin deacetylase SIRT6R21CA177925 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LOMBARD, DAVID BENNER · 2013 to 2014
$362k
NCI NIH HHS R21 CA177925NCI NIH HHS R21CA177925NHLBI NIH HHS HL-114858NHLBI NIH HHS R01 HL114858NIAID NIH HHS R01 AI036302NIGMS NIH HHS R01 GM101171NIGMS NIH HHS R01GM101171NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infection in children worldwide. Sirtuin 1 (SIRT1), an NAD(+)-dependent deacetylase, has been associated with the induction of autophagy and the regulation of inflammatory mediators. We found that Sirt1 was upregulated in mouse lung after RSV infection. Infected animals that received EX-527, a selective SIRT1 inhibitor, displayed exacerbated lung pathology, with increased mucus production, elevated viral load, and enhanced Th2 cytokine production. Gene expression analysis of isolated cell populations revealed that Sirt1 was most highly upregulated in RSV-treated dendritic cells (DCs). Upon RSV infection, EX-527-treated DCs, Sirt1 small interfering RNA-treated DCs, or DCs from conditional knockout (Sirt1(f/f)-CD11c-Cre(+)) mice showed downregulated inflammatory cytokine gene expression and attenuated autophagy. Finally, RSV infection of Sirt1(f/f)-CD11c-Cre(+) mice resulted in altered lung and lymph node cytokine responses, leading to exacerbated pathology. These data indicate that SIRT1 promotes DC activation associated with autophagy-mediated processes during RSV infection, thereby directing efficient antiviral immune responses.

Indexed as

AnimalsAutophagyCarbazolesCytokinesDendritic CellsDisease Models, AnimalGene ExpressionGene Expression RegulationMiceMice, KnockoutRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsSirtuin 16-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamideCarbazolesCytokinesSirtuin 1

Identifiers

PMID26157176
PMCPMC4530059
OpenAlexW2132871859

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.